Publications by authors named "Manisha Lamba"

Claim this Profile
C
Characterizing Cellular Expansion of Idecabtagene Vicleucel and Association with Clinical Efficacy and Safety in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Fan Wu, Xirong Zheng, Joseph Burnett, Madhan Masilamani, Wanying Zhang, Manisha Lamba

J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug-Drug Interaction Study.
Joseph Burnett, Caroline Sychterz, Jessica Katz, Faisal Shakeel, Jose Silva, Manisha Lamba

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Cellular Kinetics of Idecabtagene Vicleucel in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Fan Wu, Jian Zhou, Xirong Zheng, Madhan Masilamani, Yiming Cheng, Manisha Lamba

Clin Pharmacokinet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleophilic Ring Opening of Donor-Acceptor Cyclopropanes through Umpolung Reactivity of Organochlorophosphines: Phosphine Oxide-Functionalized Boron-Pendanted Compounds.
Braj Gopal, Manisha Lamba, Apoorv Kushwaha, Prasoon Raj Singh, T J Dhilip Kumar

Org Lett· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T-Cell Engager, Using Population Pharmacokinetics and Exposure-Response Analysis.
Brian Kiesel, Mayu Osawa, Madhan Masilamani, Merav Bar, Kevin Hsu, Manisha Lamba

Clin Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metal-Free Switchable Chemo- and Regioselective Alkylation of Oxindoles Using Secondary Alcohols.
Manisha Lamba, Prasoon Raj Singh, Tanmay, Avijit Goswami

J Org Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic F labeled biomolecules that are selective and promising for PET imaging: major advances and applications.
Manisha Lamba, Prasoon Raj Singh, Anupam Bandyopadhyay, Avijit Goswami

RSC Med Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper-Catalyzed Chemoselective O-Arylation of Oxindoles: Access to Cyclic Aryl Carboxyimidates.
Prasoon Raj Singh, Manisha Lamba, Avijit Goswami

J Org Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
Jamie N Connarn, Han Witjes, Marielle van Zutphen-van Geffen, Rik de Greef, Timothy B Campbell, Manisha Lamba

CPT Pharmacometrics Syst Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC-92480), a novel cereblon E3 ligase modulator.
Fan Wu, Liangang Liu, Allison Gaudy, Xiaomin Wang, Leon Carayannopoulos, Manisha Lamba

CPT Pharmacometrics Syst Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices.
Madhan Masilamani, Vibha Jawa, Yanshan Dai, Romita Das, Alice Park, Manisha Lamba

Clin Pharmacol Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
Paul G Richardson, Suzanne Trudel, Rakesh Popat, María-Victoria Mateos, Annette J Vangsted, Manisha Lamba

N Engl J Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Manisha Lamba

Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical pollution of the world's rivers.
John L Wilkinson, Alistair B A Boxall, Dana W Kolpin, Kenneth M Y Leung, Racliffe W S Lai, Manisha Lamba

Proc Natl Acad Sci U S A· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma.
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Nicolas Isambert, Patricia Niccoli, Manisha Lamba

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT).
Manisha Lamba, Avijit Goswami, Anupam Bandyopadhyay

Chem Commun (Camb)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology.
Joseph Kushner, Manisha Lamba, Thomas Stock, Ronnie Wang, Mary Anne Nemeth

Eur J Pharm Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
Yoshiya Tanaka, Naonobu Sugiyama, Shigeyuki Toyoizumi, Tatjana Lukic, Manisha Lamba

Rheumatology (Oxford)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenem resistance exposures via wastewaters across New Delhi.
Manisha Lamba, Sonia Gupta, Rishabh Shukla, David W Graham, T R Sreekrishnan

Environ Int· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sewage treatment effluents in Delhi: A key contributor of β-lactam resistant bacteria and genes to the environment.
Manisha Lamba, Shaikh Ziauddin Ahammad

Chemosphere· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Wastewater Releases of Carbapenem-Resistance Pathogens and Genes in Urban India.
Manisha Lamba, David W Graham, S Z Ahammad

Environ Sci Technol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance comparison of secondary and tertiary treatment systems for treating antibiotic resistance.
Manisha Lamba, Shaikh Ziauddin Ahammad

Water Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Nicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, Nikolay Tzaribachev, Daniel J Kingsbury, Manisha Lamba

Pediatr Rheumatol Online J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension.
Carmine Dario Vizza, B K S Sastry, Zeenat Safdar, Lutz Harnisch, Xiang Gao, Manisha Lamba

BMC Pulm Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.
Manisha Lamba, Rong Wang, Tracey Fletcher, Christine Alvey, Joseph Kushner

J Clin Pharmacol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis